Quarterly report pursuant to Section 13 or 15(d)

Commitments and Contingencies (Details Narrative)

v3.22.1
Commitments and Contingencies (Details Narrative)
 1 Months Ended 3 Months Ended 6 Months Ended
Oct. 31, 2021
USD ($)
Mar. 31, 2022
USD ($)
Mar. 31, 2021
USD ($)
Mar. 31, 2022
USD ($)
Mar. 31, 2022
EUR (€)
Mar. 31, 2021
USD ($)
Product Liability Contingency [Line Items]            
Research and development expenses   $ 6,405,273 $ 3,840,399 $ 10,671,138   $ 7,706,407
Payment to acquire in process research and development       285,627  
Discovery Collaboration Agreements [Member] | XOMA [Member]            
Product Liability Contingency [Line Items]            
Milestone payments       3,800,000    
Collaboration Agreement [Member]            
Product Liability Contingency [Line Items]            
Research and development expenses   $ 500,000        
The Brink Agreement [Member]            
Product Liability Contingency [Line Items]            
[custom:PaymentForAnnualLicenseFeeObligation] $ 100,000          
[custom:CommericalProductLicenseFeePaymentObligation] $ 100,000          
The Brink Agreement [Member] | In Process Research and Development [Member]            
Product Liability Contingency [Line Items]            
[custom:CommericalProductLicenseFeePaymentObligation]       100,000    
The InvivoGen Agreement [Member]            
Product Liability Contingency [Line Items]            
[custom:PaymentForAnnualLicenseFeeObligation]       100,000 € 100,000  
The InvivoGen Agreement [Member] | In Process Research and Development [Member]            
Product Liability Contingency [Line Items]            
[custom:PaymentForAnnualLicenseFeeObligation]       100,000    
The ProteoNic Agreement [Member]            
Product Liability Contingency [Line Items]            
Milestone payments       1,300,000 1,200,000  
[custom:PaymentForAnnualLicenseFeeObligation]       27,500 € 25,000  
Navigo Agreement [Member] | Navigo Proteins GmbH [Member] | Technology Service [Member]            
Product Liability Contingency [Line Items]            
Milestone payments       1,000,000.0    
Payment to acquire in process research and development       $ 100,000